135 related articles for article (PubMed ID: 16343210)
1. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.
Nagai N; Hirata E; Kusuda T; Mukai K; Arihiro K; Ohama K
Int J Gynecol Cancer; 2005; 15(6):1187-90. PubMed ID: 16343210
[TBL] [Abstract][Full Text] [Related]
2. Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastases.
Utsugi K; Shimizu Y; Akiyama F; Hasumi K
Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):186-8. PubMed ID: 12381485
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
5. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
Datta CK
W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
Huang X; Lan C; Huang H; Zhang Y; Huang H; Cao X; Huang Y; Guo Y; Wan T; Liu J
Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.
Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K
Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140
[TBL] [Abstract][Full Text] [Related]
8. Villoglandular papillary adenocarcinoma of the cervix: case report.
Lakhtakia R; Singh MK; Taneja P; Kapila K; Kumar S
J Surg Oncol; 2000 Aug; 74(4):297-9. PubMed ID: 10962465
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
10. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
Reed W; Abeler VM; Tropé CG
Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma--a preliminary study.
Saito T; Takehara M; Lee R; Fujimoto T; Nishimura M; Tanaka R; Ito E; Adachi K; Kudo R
Int J Gynecol Cancer; 2004; 14(3):483-90. PubMed ID: 15228422
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Park DC; Suh MJ; Yeo SG
Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
[TBL] [Abstract][Full Text] [Related]
14. Villoglandular papillary adenocarcinoma of the uterine cervix: report of a case.
Borgo G; Feyles E; Gaglio A; Tagliani L; Andrion A
Tumori; 1998; 84(6):717-9. PubMed ID: 10080684
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
Tsubamoto H; Maeda H; Kanazawa R; Ito Y; Ohama N; Hori M; Ikeda Y; Kato T; Sakane R; Hirota S
Gynecol Oncol; 2013 Apr; 129(1):129-34. PubMed ID: 23333929
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Iwasaka T; Fukuda K; Hara K; Yokoyama M; Nakao Y; Uchiyama M; Sugimori H
Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.
Lu Q; Zhang Y; Wang S; Guo S; Guo H; Zhang Z; Liu C
Fertil Steril; 2014 Mar; 101(3):812-7. PubMed ID: 24439996
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
[TBL] [Abstract][Full Text] [Related]
19. [Three cases of uterine cervical adenocarcinoma successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)].
Narimatsu A; Okada O
Gan To Kagaku Ryoho; 1996 Jan; 23(1):111-4. PubMed ID: 8546460
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
